跳至主要内容
临床试验/NL-OMON41410
NL-OMON41410已完成不适用

Higher diagnostic accuracy and cost-effectiveness using a novel biomarker for Treatment in Emergency Medicine Patients with fever - HiTEMP

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 550 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 未提供

排除标准

  • under 18 years of age. Pregnant patients. Immunocompromised patients (neutropenia, defined as an absolute neutrophil count less than 0.5x109/L, current chemotherapy, transplantation patients), predetermined illness with an expected death within 24 hours. Surgical fever, defined as fever within 72 hours post-surgery, or patients with a primary surgical diagnosis.

研究者

相似试验